Neogen Overview
- Founded
-
1982
- Status
-
Public
- Employees
-
2,108
- Stock Symbol
-
NEOG
- Investments
-
49
- Share Price
-
$19.96
- (As of Monday Closing)
Neogen General Information
Description
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for global food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Contact Information
Primary Industry
Other Commercial Products
Stock Exchange
NAS
Primary Office
- 620 Lesher Place
- Lansing, MI 48912
- United States
+1 (800) 000-0000
Neogen Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.96 | $20.04 | $10.49 - $36.90 | $4.3B | 216M | 3.31M | -$0.04 |
Neogen Financials Summary
|
In Thousands, USD |
TTM 30-Nov-2022 | FY 2022 31-May-2022 | FY 2021 31-May-2021 | FY 2020 31-May-2020 |
|---|---|---|---|---|
| EV | 3,231,032 | 2,473,862 | 4,603,700 | 3,440,386 |
| Revenue | 630,719 | 527,159 | 468,459 | 418,170 |
| EBITDA | 42,456 | 82,634 | 94,695 | 84,709 |
| Net Income | (16,230) | 48,307 | 60,882 | 59,475 |
| Total Assets | 4,563,242 | 992,929 | 920,192 | 797,182 |
| Total Debt | 923,962 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Neogen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Neogen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food an
Other Commercial Products
Lansing, MI
2,108
As of 2022
0000
0000
0000
000 00
si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
00000 0000000000 000
Cranberry Township, PA
0000
As of 0000
000000 - 000
0000 0
la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
00000 0000000000 000
Libourne, France
0000
As of 0000
00000
00 000000
00000
Add Comparison
Neogen Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MSA Safety | Corporation | Cranberry Township, PA | 0000 | 000000 - 000 | ||
| 0000 00000 0000000 | Private Equity-Backed | Libourne, France | 0000 | 00000 | 00 000000 | 00000 |
Neogen Patents
Neogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220315991-A1 | Detecting salmonella from an environmental sample | Pending | 31-Mar-2021 | 000000000 | |
| US-20220062563-A1 | Hypodermic interface assembly | Pending | 01-Sep-2020 | 0000000000 | |
| US-20220031961-A1 | Hypodermic interface assembly | Pending | 28-Jul-2020 | 0000000000 | 0 |
| US-20220031962-A1 | Hypodermic interface assembly | Pending | 28-Jul-2020 | 000000000 | |
| US-D839380-S1 | Bait station | Active | 17-Aug-2017 |
Neogen Executive Team (29)
Neogen Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Catherine Woteki | Neogen | Board Member | 000 0000 |
| Darci Vetter | Neogen | Board Member | 000 0000 |
| James Borel | Self | Chairman & Board Member | 000 0000 |
| James Tobin | Neogen | Board Member | 000 0000 |
| Jeffrey Capello | Neogen | Board Member | 000 0000 |
Neogen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Neogen Investments & Acquisitions (49)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00 (00'0 0000 | 01-Sep-2022 | 0000000000 | 00.00 | Other Commercial Products | 0000 0000 |
| 0000-000 0000 | 01-Jul-2022 | 0000000000 | 00.000 | Distributors/Wholesale | 00000 000 |
| 000 00000 000 | 09-Dec-2021 | 0000000000 | 000.00 | Laboratory Services (Healthcare) | 00000000 |
| 000000 000000 | 30-Nov-2021 | 0000000000 | Laboratory Services (Healthcare) | ||
| Delf (UK) | 30-Nov-2021 | Merger/Acquisition | Industrial Chemicals | 00000 000 |
Neogen Subsidiaries (13)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| CAPInnoVet | Pharmaceuticals | Atlanta, GA | 2014 |
| 000 00000 00000000 | Laboratory Services (Healthcare) | Spokane, WA | 0000 |
| 00000 000000000000 | Biotechnology | Aracatuba, Brazil | 0000 |
| 000000 0000000000 | Laboratory Services (Healthcare) | London, United Kingdom | 0000 |
| 0000000000 | Distributors/Wholesale | Milan, Italy | 0000 |
Neogen ESG
Risk Overview
Risk Rating
Updated June, 03, 2022
19.18 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
00.0
Percentile
Healthcare
Industry
00 of 635
Rank
00.00
Percentile
Medical Supplies
Subindustry
00 of 59
Rank
00.00
Percentile
